Femasys Inc
FEMY- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001339005
In the last 90 days, Femasys Inc insiders filed 5 open-market purchases and 0 sales; 19 institutions reported holding it in 13F filings for Q2 2026, worth $8.65M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Femasys Inc changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Of which not filed for Q2 2023 | Q2 2023 | Change |
|---|---|---|---|---|
| Holders | 19 | 1 | 22 | +4 |
| Shares | 1.30M | 49.7K | 1.29M | +36.8K (+2.9%) |
| Value | $1.28M | $0 | $624.6K | −$655.0K (−51.2%) |
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (4)
Institutions that held Femasys Inc at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 11,500 | $6.00K | 0.00% |
| Millennium Management LLC | 10,891 | $5.55K | 0.00% |
| JPMorgan Chase & Co | 3,105 | $1.58K | 0.00% |
| Meitav Dash Investments Ltd | 10,344 | – | – |
Sold out (0)
Institutions that held Femasys Inc at the end of Q1 2023 and filed for Q2 2023 without it.
None.
Not filed for Q2 2023 yet (1)
Institutions that held Femasys Inc at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Coppell Advisory Solutions Corp. | 49,734 | – |